Ritesh K. Aggarwal

Ritesh K. Aggarwal, Ph.D. is a researcher at Albert Einstein College of Medicine specializing in oncology with a focus on hematological malignancies and inflammatory immune responses.

His primary research interests include:

• Myelodysplastic Syndrome (100% focus)
• Acute Myeloid Leukemia (68% focus)
• Inflammatory Immune Response (60% focus)
• Cancer Immunology
• Molecular Pathology of Hematological Malignancies

Dr. Aggarwal's research program investigates the molecular mechanisms connecting inflammatory pathways to hematological malignancies. His recent publications demonstrate a strong emphasis on translational research, particularly examining how smoking affects prognosis in myelodysplastic syndromes, the role of IRAK4 in lung carcinogenesis, and transcriptional regulation in T-cell leukemia. His work bridges basic science discoveries with clinical applications in oncology, with particular attention to targetable signaling pathways in myelodysplastic syndromes with SF3B1 mutations.

Key scientific contributions include:

• Research on inflammatory immune signaling in myelodysplastic syndromes (55 Scopus citations)
• Studies on smoking-associated carcinogenesis via IRAK4 activation
• Identification of ETS1 as a novel transcriptional regulator in adult T-cell leukemia
• Narrative reviews synthesizing knowledge on inflammatory pathways in hematological malignancies (21 Scopus citations)